Company / Book Value per Share
TherapeuticsMD, Inc. Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$2.54
FY2024
5-year range
-$10.889 / $3.7
FY2020-FY2024
Trend
-31.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has fluctuated over the past 10 years, ranging from -$10.889 in FY2022 to $3.7 in FY2023.
Based on SEC 10-K filings.
$2.54 in FY2024 with a 5-year CAGR of +36.3%.
Improved from -$10.889 to $2.54 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +36.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +36.3%, indicating consistent growth.
- In FY2024, book value per share decreased 31.4% year-over-year.
- Peak book value per share was recorded in FY2023.
- Lowest book value per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.54 | -31.4% |
| FY2023 | $3.7 | +134.0% |
| FY2022 | -$10.889 | -2532.3% |
| FY2021 | -$0.414 | -215.0% |
| FY2020 | $0.36 | -33.4% |
| FY2019 | $0.54 | -8.3% |
| FY2018 | $0.589 | +83.7% |
| FY2017 | $0.321 | +17.9% |
| FY2016 | $0.272 | -27.9% |
| FY2015 | $0.377 | +3916.7% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026